Standout Papers

Hematological find... 1996 2026 2006 2016 1.1k
  1. Hematological findings and complications of COVID‐19 (2020)
    Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos et al. American Journal of Hematology
  2. Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma (2007)
    Meletios Α. Dimopoulos, Andrew Spencer et al. New England Journal of Medicine
  3. Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors (2005)
    Aristotle Bamias, Efstathios Kastritis et al. Journal of Clinical Oncology
  4. Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma (1996)
    James R. Berenson, Alan Lichtenstein et al. New England Journal of Medicine
  5. New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes (2012)
    Giovanni Palladini, Angela Dispenzieri et al. Journal of Clinical Oncology
  6. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia (2003)
    Roger G. Owen, Steven P. Treon et al. Seminars in Oncology
  7. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2017)
    Philippe Moreau, Jesús F. San Miguel et al. Annals of Oncology
  8. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† (2021)
    Meletios Α. Dimopoulos, Philippe Moreau et al. Annals of Oncology
  9. Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma (2018)
    Meletios Α. Dimopoulos, Dominik Dytfeld et al. New England Journal of Medicine
  10. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study (2020)
    Meletios Α. Dimopoulos, Hang Quach et al. The Lancet
  11. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications (2021)
    Ioannis P. Trougakos, Κimon Stamatelopoulos et al. Journal of Biomedical Science
  12. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis (2022)
    Ioannis P. Trougakos, Evangelos Terpos et al. Trends in Molecular Medicine

Immediate Impact

4 by Nobel laureates 2 from Science/Nature 100 standout
Sub-graph 1 of 15

Citing Papers

Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
Unexplained post-acute infection syndromes
2022 Standout
1 intermediate paper

Works of Meletios Α. Dimopoulos being referenced

Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review
2021
Proteasome dysfunction inDrosophilasignals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging
2013

Author Peers

Author Last Decade Papers Cites
Meletios Α. Dimopoulos 23206 22523 20698 1.7k 49.6k
Robert A. Kyle 33182 18835 34291 1.0k 58.3k
Angela Dispenzieri 24765 15184 30738 961 46.2k
Donna Neuberg 12077 13815 14045 713 45.2k
Bart Barlogie 30064 18006 24023 696 41.6k
S. Vincent Rajkumar 37605 20954 32817 885 52.1k
Philippe Moreau 18794 13840 17218 989 31.1k
Michael Andreeff 15751 13420 25506 987 47.2k
Kenneth C. Anderson 41282 30005 46654 1.4k 75.4k
Morie A. Gertz 20063 13328 29428 930 42.6k
Razelle Kurzrock 6804 24289 20512 1.2k 58.6k

All Works

Loading papers...

Rankless by CCL
2026